Phase 2 Randomized, Double-Blind, Placebo-Controlled Trial of RG7667, a Combination Monoclonal Antibody, for Prevention of Cytomegalovirus Infection in High-Risk Kidney Transplant Recipients

Cytomegalovirus (CMV) infection is a significant complication after kidney transplantation. We examined the ability of RG7667, a combination of two monoclonal antibodies, to prevent CMV infection in high-risk kidney transplant recipients in a randomized, double-blind, placebo-controlled trial. CMV-s...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Gepubliceerd in:Antimicrob Agents Chemother
Hoofdauteurs: Ishida, Julie H., Patel, Anita, Mehta, Aneesh K., Gatault, Philippe, McBride, Jacqueline M., Burgess, Tracy, Derby, Michael A., Snydman, David R., Emu, Brinda, Feierbach, Becket, Fouts, Ashley E., Maia, Mauricio, Deng, Rong, Rosenberger, Carrie M., Gennaro, Lynn A., Striano, Natalee S., Liao, X. Charlene, Tavel, Jorge A.
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: American Society for Microbiology 2017
Onderwerpen:
Antiviral Agents
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC5278717/
https://ncbi.nlm.nih.gov/pubmed/27872061
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.01794-16
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items